In-Person Instruction

DIA Professional
Development for
a Global Audience

DIA’s highly rated instructor-led training courses are designed to inform and educate professionals and experts on critical issues related to pharmaceuticals, biotechnology, and medical products.

Courses on more than 50 topics provide professionals from industry, government, and academia with the opportunity to exchange ideas, knowledge, and best practices with peers and expert instructors. Courses offered range from European regulatory affairs to drug development to safety inspection preparation.

In addition to expert instruction, each course participant receives a comprehensive set of lesson materials that is consistent across courses.

Review the list of courses below to get more information on:

What You will Learn in Pharmaceutical, Biotechnology, Medical Devices, and Related Areas
Specific Learning Objectives
Target Audiences
Contact Information

Sign up today for DIA’s instructor-led courses and discover why these innovative professional development forums are valued by a growing global audience of pharmaceutical, biotechnology, medical device, and other professionals.

North America Training
Catalog

Read

Europe Training
Catalogue

Read

Instructor-Led Courses

Title
Advanced Clinical Statistics for Nonstatisticians	10386
Advanced Clinical Vendor Oversight: Vendor Life Cycle Management	2124278
Advanced GCP Study Monitoring	24056
An Introduction to Product Information Management	17118
Art of Writing a Clinical Overview	24458
Authorisation of Biopharmaceuticals, Biosimilars and Advanced Therapies in Europe	26005
Benefit/Risk Management	29255
Building the eCTD: Practical Solutions to Compile Electronic Submissions	14773
Clinical Aspects of Quality Risk Management and Quality by Design	2088939
Clinical Project Management	13242
Clinical Project Management in Europe	20842
Clinical Statistics for Nonstatisticians	10381
Comprehensive Training on European Regulatory Affairs including Different Registration Procedures and Variations: Expert Overview	17165
Crisis Management	23589
Developing Standard Operating Procedures	10380
Development of a Clinical Study Report	10379
Diagnosis and Management of Drug-Induced Liver Injury (DILI)	2162769
Electronic Submissions: The Next Era of Electronic Submissions	2526234
EMA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing	14767
Enterprise Resource Management	16489
Essentials of Clinical Study Management	15325
Essentials of Project Management	10308
European Regulatory Affairs	10377
Executing and Controlling Biopharmaceutical Projects	11335
Fundamentals of Clinical Research Monitoring	10376
Fundamentals of Project Management for the Nonproject Manager	10309
Global Considerations for Regulatory Strategy Development	30108
Global CTD Dossier – Regulatory aspects and focus on quality documentation including concepts of Quality by Design	20794
Good Clinical Practices for the Clinical Research Professional	10375
Good Management of Medical Devices including In Vitro Diagnostics and Companion Diagnostics: Legal and practical aspects of devices	23033
Health Authority Interactions – Preparation, consultation and implementation	2088953
Health Technology Assessment (HTA)	27760
High Performance Biopharm Teams	14215
How to Prepare for a Safety Inspection	20691
How to Prepare for Pharmacovigilance Audits and Inspections in Europe	21617
Introduction to Clinical Data Management	10382
Introduction to Computer Systems Validation	19537
Introduction to Portfolio Management and Performance Metrics	16188
Introduction to Signal Detection and Data Mining	20694
Leadership Experience	10311
Medical Approach in Diagnosis and Management of ADRs	11120
Navigating Chemistry, Manufacturing and Controls through the Drug Development Process	19367
New Drug Product Development and Life Cycle Management	13461
Non-Clinical Safety Sciences and Their Regulatory Aspects	17110
Overview of Drug Development	10310
Overview of Drug Development in Japan	12679
Paediatric Investigation Plans (PIP)	29280
Postmarketing Drug Safety and Pharmacovigilance	21684
Practical GCP Compliance Auditing of Trials & Systems	11095
Practical Guide for Pharmacovigilance: Clinical Trials and Post Marketing	17166
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum	29675
Pre-marketing Clinical Safety	2164753
Premarketing Clinical Safety and Pharmacovigilance	21656
Preparing for a US FDA Advisory Committee Meeting	28296
Project Information, Communication, and Knowledge Management	16153
Project Risk Management	16145
Proven Strategies for Creating an Effective Clinical Research Program	28775
Quality by Design for Chemical and Biotech Products – A hands-on course for the pharmaceutical industry and regulators	23689
Regulatory Affairs for Biologics	21649
Regulatory Affairs Part I: The IND Phase	10307
Regulatory Affairs Part II: The NDA Phase	10306
Regulatory Affairs: The IND, NDA, and Postmarketing	10305
Risk Management and Safety Communication Strategies	22320
Signal Management in Pharmacovigilance	21608
Strategies for Good Clinical Practice Audits	10374
The Impact of Regulatory Affairs on Chemistry, Manufacturing & Controls (CMC)	29401
Training Course for eCTD Submissions in Switzerland	23714
US Regulatory Affairs: A Comprehensive Review of Regulatory Procedures for INDs and NDAs in the US	11122
Using Pharmacokinetic and Pharmacodynamic Principles to Enable IND and NDA Submissions	28297
Who's Monitoring the Monitor? Trends, Management Techniques and a Reality-Check for Sponsors Utilizing CRO and Alliance-based Site Monitoring	13871

Share

In-Person Instruction

Instructor-Led Courses